REGENEREX PHARMA, INC. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
REGENEREX PHARMA, INC. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $1.03 million as of 2014-11-30, per its 10-K filed 2015-03-03.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2015-03-03
- 2014-11-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $1.03M.
- 2014-08-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $981.18K.
- 2014-05-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $922.04K; Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed -$922.04K.
- 2014-02-28: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) -$2.07M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) as first filed |
|---|---|---|
| 2014-11-30 | $1.03M 10-K · filed 2015-03-03 | |
| 2014-08-31 | $981.18K 10-Q · filed 2014-10-20 | |
| 2014-05-31 | $922.04K 10-Q · filed 2014-07-23 | -$922.04K 10-Q · filed 2014-07-16 |
| 2014-02-28 | -$2.07M 10-Q · filed 2014-04-11 | |
| 2013-11-30 | $1.89M 10-K · filed 2015-03-03 | -$1.89M 10-K · filed 2014-02-28 |
| 2012-11-30 | -$898.22K 10-K · filed 2014-02-28 | |
| 2012-08-31 | -$405.51K 10-Q · filed 2012-10-15 | |
| 2012-05-31 | -$391.09K 10-Q · filed 2012-07-16 | |
| 2011-11-30 | -$238.49K 10-K · filed 2013-02-28 | |
| 2011-08-31 | -$53.29K 10-Q · filed 2011-10-13 | |
| 2010-11-30 | -$26.34K 10-Q · filed 2011-10-13 |